1. Current and future issues in the manufacturing and development of monoclonal antibodies;Kozlowski;Adv Drug Deliv Rev,2006
2. Well-characterized biotechnology products; elimination of establishment license application;FDA;Federal Register,1996
3. FDA, reform, and the well-characterized biologic;Henry;Anal Chem,1996
4. International Conference on Harmonisation Guideline. Specifications: test procedures and acceptance criteria for biotechnological/biological products (Q6B);Federal Register,1999
5. Update on therapeutic monoclonal antibodies;Bussel;Curr Probl Pediatr Adolesc Health Care,2007